1 study found for:    B1271004
Show Display Options
Rank Status Study
1 Terminated A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Condition: Endometrial Neoplasms
Intervention: Drug: PF-05212384

Indicates status has not been verified in more than two years